VRAX

Virax Biolabs Group Limited Ordinary Shares (VRAX)

Stock · NASDAQ · Health Care

$1.42as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

VRAX in Monday session gap up/down market activity. VRAX was among the stocks that moved in the opening and closing gaps during Monday’s session, according to ChartMill. The gaps were part of a broader market pattern and did not reflect any new company‑specific information. The move left VRAX trading near its 12‑touch support level of $2.81.

Active signals

Resistance level
$2.71
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances

What VRAX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band BreakdownActive now16-2.4%38%
Bollinger Band Breakout15-21.7%33%
Volume Spike12-19.1%25%
Any 20-session window (baseline)-11.5%27%

Computed by MarketWall from daily closing prices since May 5, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About VRAX

Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic e…

Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Employees
26

Fundamentals

1-day range
$1.38$1.64
Market cap
$2.21M
P/E (trailing)
—
P/E (forward)
-0.24
EPS (trailing)
$-23.09
Dividend yield
—
Beta
1.47
Avg. volume
409.4K
52-week range
$1.55$21.75

Forecasts

1 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$25
+1666.8%
Median
$25
+1666.8%
Low
$25
+1666.8%

Virax Biolabs Group Limited Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • VRAX
    Virax Biolabs Group Limited Ordinary Shares
    $1.45
    ▼ 10.49%
    Market cap $2.21MP/E —
    $1.55$21.75
  • CDIOW
    Cardio Diagnostics Holdings Inc. Warrant
    $0.0064
    ▼ 28.09%
    Market cap $50.3KP/E —
    $0.0052$0.0721
  • CDIO
    Cardio Diagnostics Holdings Inc. Common stock
    $1.69
    ▼ 3.98%
    Market cap $4.91MP/E —
    $0.97$7.91
  • BMRA
    Biomerica Inc. Common Stock
    $1.85
    ▼ 1.60%
    Market cap $4.94MP/E —
    $1.45$3.21
  • TRIB
    Trinity Biotech plc American Depositary Shares
    $8.03
    ▲ 1.26%
    Market cap $7.86MP/E —
    $5.01$52.5
  • VNRX
    VolitionRX Limited Common Stock
    $0.18
    ▼ 5.26%
    Market cap $9.23MP/E —
    $0.18$10.31
  • QCLS
    Q/C Technologies Inc. Common Stock
    $0.538
    ▼ 3.58%
    Market cap $21.99MP/E —
    $0.4201$8.17

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.